{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-26-000021","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2026-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.953076+00:00","generated_at":"2026-05-15T04:24:40.446136+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Edwards Q1 sales +16.7% to $1.65B; raises FY guidance on TAVR strength","bullets":["Q1 sales $1.65B, +16.7% YoY; constant currency +12.7%; TAVR sales $1.20B, +14.4%.","GAAP EPS $0.66; adjusted EPS $0.78, beating consensus; gross margin 78.0%.","Raises FY 2026 constant currency sales growth guidance to 9-11% (from 8-10%); new TAVR growth 7-9%.","Raises FY adjusted EPS guidance to $2.95-$3.05 from $2.90-$3.05; sees Q2 sales $1.66-$1.74B.","Completed $500M ASR; $1.5B remaining buyback authorization; cash $2.4B, debt $0.6B."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-26-000021","json":"https://secwatch.observer/filing/0001099800-26-000021.json","markdown":"https://secwatch.observer/filing/0001099800-26-000021.md","text":"https://secwatch.observer/filing/0001099800-26-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000021/0001099800-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000021/ew-20260423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T04:24:40.446136+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"80210a5ab5c0e359173d0961a03f53fa8dc0bd64","claim":"Edwards Lifesciences Corp updated its first quarter of 2026 guidance (raised).","evidence_excerpt":"issued a press release setting forth Edwards' financial results for the first quarter of 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000021/0001099800-26-000021-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of 2026"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}